Interstitial Photodynamic Therapy (PDT) for the Treatment of Patients with Locally Advanced or Recurrent Head and Neck Cancer - Summary - MDSpire
Advertisement
Interstitial Photodynamic Therapy (PDT) for the Treatment of Patients with Locally Advanced or Recurrent Head and Neck Cancer
An NCI/NIH funded Phase 1/2 clinical study (NCT03727061) will evaluate the safety and efficacy of adjuvant Photofrin® mediated I-PDT in patients with locally advanced or recurrent HNC who failed to respond to standard therapy and are not amenable to standard curative treatment.
To evaluate the safety and efficacy of adjuvant Photofrin® mediated interstitial photodynamic therapy (I-PDT) in patients with locally advanced or recurrent head and neck cancer who have not responded to standard therapy.
Key Findings:
Preliminary experience suggests potential benefits of I-PDT for head and neck cancer.
The study aims to assess both safety and efficacy of the treatment.
Interpretation:
I-PDT using Photofrin® may provide a new therapeutic option for patients with limited treatment alternatives.
Limitations:
Preliminary nature of the findings.
Limited patient population due to specific inclusion criteria.
Conclusion:
The ongoing study may pave the way for new treatment strategies in advanced head and neck cancer.
